Latest Breaking News On - கேன் குழு - Page 1 : comparemela.com

ASX health stocks: 4D Medical leads after ramping up its game in the US Health & Biotech share clipboard ASX 200 health stocks index rose by 0.68% this morning, compared to the broader index which rose by 0.24%. Respiratory device specialist, In its quarterly update,  the company said it has ramped up commercialisation activities following the rapidly growing vaccination uptake in the US. This, 4DX says,  will allow for greater access to key decision makers at hospitals and medical institutions, where it plans to commence several clinical trials for its of XV Lung Ventilation Analysis Software (XV LVAS). 4DX also reported a cash balance of $80.9 million as at 30 June, with net operating cash outflows for the quarter of $0.6 million, which includes $7.1 million received in government grants and tax incentives and $0.6 million in receipts from customers.

United statesAlex keachMurray medsAlivio spolkaDoug flynnGarvan institute of medical researchXv lung ventilation analysis softwareCann groupVentilation analysis softwareGarvan instituteMedical researchClinical investigationஒன்றுபட்டது மாநிலங்களில்முர்ரே மேட்ச்டக் ஃப்லிந்கார்வான் நிறுவனம் ஆஃப் மருத்துவ ஆராய்ச்சி